Cream Clinical Study for Mild to Moderate Eczema

We know these are challenging times and venturing out can be especially stressful. We want you to know that at CRCC we have implemented every safety measure possible to keep you safe and prevent the spread of Covid-19. Patient areas are continually disinfected, social distancing is enforced in our lobby, and all staff wear masks/gloves throughout the day. If you arrive for your appointment and wish to wear a mask, we will provide one for you as well.

We are seeking patients that meet the below criteria to participate in a study to evaluate the safety and efficacy of ARQ-151 cream versus placebo in adult and adolescent subjects with mild to moderate atopic dermatitis (eczema).

  • History of eczema for at least 3 months in subjects 6-17 years of age or 6 months in subjects 18 years of age
  • Must have eczema involvement of 3% or greater of body surface area, excluding the scalp, palms, and soles  (1% is approximately equivalent to the size of your palm)
  • Be available for 5 office visits

If you are interested in participating in one of these studies, please provide your contact information below. If you are a qualified candidate, a representative from our research department will be in touch with you.

Volunteer for this study!

  • This field is for validation purposes and should be left unchanged.